Registry for Hantavirus Infections

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to collect and analyze data on hantavirus infections, specifically focusing on hemorrhagic fever with renal syndrome (HFRS) and hantavirus cardiopulmonary syndrome (HCPS). It will gather retrospective data from patients with confirmed hantavirus infections to better understand the clinical course, mortality rates, and associated healthcare costs. The study is motivated by the increasing incidence of hantavirus outbreaks in Europe and the need for more comprehensive data on these zoonotic infections.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Serological or molecular evidence of hantavirus infection and clinical evidence of nephropathia epidemica or hemorrhagic fever with renal syndrome (HFRS)
* Serological or molecular evidence of hantavirus infection and clinical evidence of hantavirus cardiopulmonary syndrome (HCPS)

Exclusion Criteria:

\- Serological or molecular evidence of hantavirus infection without clinical signs of nephropathia epidemica, HFRS or HCPS

Where it's running

• University Hospital of Cologne
  Cologne, North-Rhine Westfalia, Germany Recruiting

Study contacts

• Principal investigator: Volker Burst, MD — University Hospital of Cologne
• Study coordinator: Felix Köhler, MD
• Email: felix.koehler@uk-koeln.de
• Phone: +4922147897222

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Turning anonymous symptom descriptions into structured biological signals with OpenGenome

  This project tries to turn adults' anonymous free-text symptom descriptions submitted to OpenGenome into structured, literature-grounded biological signals using PubMed and ClinicalTrials.gov sources and a constrained reasoning model.

  Recruiting OpenGenome · Friedrichshain, State of Berlin · NCT07578610

• Community spread of multiple infectious diseases in Cambodia from a One Health perspective

  This project will test how common and connected dengue, chikungunya, Zika, Japanese encephalitis, and West Nile infections are among people, animals, and the environment across Cambodia.

  Recruiting Institut Pasteur du Cambodge · Phnom Penh, Phnom Penh · NCT07358910

• Dapagliflozin to slow kidney decline in autosomal dominant polycystic kidney disease

  This will test if taking dapagliflozin every day slows kidney function loss in adults 18–60 with rapidly progressing ADPKD.

  Recruiting at 24 sites Phase 3 University of Cologne · Feldkirch and 29 other locations · NCT07280585

• Improving care for patients with extrapulmonary tuberculosis

  This study is trying to improve care for adults newly diagnosed with extrapulmonary tuberculosis by collecting their health information and samples to better understand the disease.

  Recruiting at 4 sites University of Cologne · Bonn and 5 other locations · NCT06875336

• Understanding vaccine responses in immunocompromised patients

  This study looks at how well vaccines work for people with weakened immune systems, like those with blood cancers or on certain treatments, to help improve their protection against respiratory viruses.

  Recruiting University of Cologne · Cologne, North Rhine-Westphalia · NCT06612515

• Comparing cataract surgery with a new corneal transplant technique for patients with cataracts and Fuchs dystrophy

  This study is testing whether a new corneal transplant technique combined with cataract surgery can improve vision and quality of life for people with cataracts and Fuchs dystrophy compared to standard cataract surgery alone.

  Recruiting University of Cologne · Aarhus N, Central Jutland and 3 other locations · NCT06425666

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.